Free Trial

OptimizeRx (OPRX) SEC Filings & 10K Form

OptimizeRx logo
$13.99 -0.18 (-1.27%)
Closing price 04:00 PM Eastern
Extended Trading
$14.02 +0.03 (+0.21%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent OptimizeRx SEC Filings

DateFilerForm TypeView
07/16/2025
10:35 AM
OptimizeRx (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SCHEDULE 13G/A
06/24/2025
6:45 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2025
3:31 PM
OptimizeRx (Issuer)
WASSON GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:33 PM
OptimizeRx (Issuer)
Vos Ellen O'Connor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:34 PM
OptimizeRx (Issuer)
Spangler Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:35 PM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:36 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
7:30 AM
OptimizeRx (Filer)
Form DEF 14A
04/30/2025
7:32 AM
OptimizeRx (Filer)
Form ARS
04/21/2025
1:47 PM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form SCHEDULE 13D/A
04/07/2025
11:15 PM
OptimizeRx (Filer)
Form EFFECT
03/28/2025
3:30 PM
OptimizeRx (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:46 PM
OptimizeRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
6:40 PM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:45 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
6:45 AM
OptimizeRx (Filer)
Form DEFA14A
03/10/2025
7:58 PM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form DFAN14A
03/10/2025
4:29 PM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form SCHEDULE 13D/A
03/10/2025
6:45 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
8:16 AM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:18 AM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:38 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:39 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:39 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:40 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:40 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
2:58 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
9:34 AM
OptimizeRx (Subject)
Samjo Management, LLC (Filed by)
Form SCHEDULE 13G/A
02/05/2025
10:41 AM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form SCHEDULE 13D
02/04/2025
5:50 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
11:58 AM
OptimizeRx (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SCHEDULE 13G
01/08/2025
3:37 PM
First Light Asset Management, LLC (Filed by)
OptimizeRx (Subject)
Form SCHEDULE 13G/A
12/27/2024
4:00 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:38 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
12/27/2024
2:18 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:08 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:08 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:09 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
7:50 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:46 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:47 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Banks aren’t ready for this altcoin—are you? (Ad)

The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.

Discover the protocol that crypto whales are secretly accumulating...
12/20/2024
6:47 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:48 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
1:28 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:18 PM
AWM Investment Company, Inc. (Filed by)
OptimizeRx (Subject)
Form SC 13G
11/14/2024
10:25 AM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G/A
11/13/2024
9:25 AM
OptimizeRx (Subject)
Samjo Management, LLC (Filed by)
Form SC 13G
11/12/2024
8:37 AM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
7:30 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:53 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:30 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:26 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:25 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
4:22 PM
McCarthy Brian Clark (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:45 PM
OptimizeRx (Filer)
Form S-8 POS
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OPRX) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners